Page last updated: 2024-09-04

conivaptan and opc 51803

conivaptan has been researched along with opc 51803 in 1 studies

Compound Research Comparison

Studies (conivaptan)	Trials (conivaptan)	Recent Studies (post-2010) (conivaptan)	Studies (opc 51803)	Trials (opc 51803)	Recent Studies (post-2010) (opc 51803)
188	17	64	9	0	2

Protein Interaction Comparison

Protein	Taxonomy	conivaptan (IC50)	opc 51803 (IC50)
Vasopressin V2 receptor	Homo sapiens (human)		0.33
Vasopressin V2 receptor	Rattus norvegicus (Norway rat)		0.23

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, JAJ; Bonnet, D; Durroux, T; Frantz, MC; Gandía, J; Hibert, M; Le Merrer, J; Loison, S; Marsol, C; Mouillac, B; Pellissier, LP; Pflimlin, E; Valencia, C; Villa, P	1

Other Studies

1 other study(ies) available for conivaptan and opc 51803

Article	Year
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism. Journal of medicinal chemistry, 2018, 10-11, Volume: 61, Issue:19 Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Disease Models, Animal; Female; HEK293 Cells; Humans; Interpersonal Relations; Ligands; Male; Mice; Mice, Knockout; Psychotropic Drugs; Pyrazoles; Pyrrolidines; Receptors, Opioid, mu; Receptors, Oxytocin; Structure-Activity Relationship	2018

Article

Year

LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.

Journal of medicinal chemistry, 2018, 10-11, Volume: 61, Issue:19

Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Disease Models, Animal; Female; HEK293 Cells; Humans; Interpersonal Relations; Ligands; Male; Mice; Mice, Knockout; Psychotropic Drugs; Pyrazoles; Pyrrolidines; Receptors, Opioid, mu; Receptors, Oxytocin; Structure-Activity Relationship

2018